EMEA-001720-PIP01-14-M02
Key facts
Invented name |
Veltassa
|
Active substance |
Patiromer calcium
|
Therapeutic area |
Other
|
Decision number |
P/0367/2021
|
PIP number |
EMEA-001720-PIP01-14-M02
|
Pharmaceutical form(s) |
Powder for oral suspension
|
Condition(s) / indication(s) |
Treatment of hyperkalaemia
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Vifor Fresenius Medical Care Renal Pharma France
Tel. +41 5885 18275 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|